相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Efficacy and Safety of a Pegasparaginase-Based Chemotherapy Regimen vs an L-asparaginase-Based Chemotherapy Regimen for Newly Diagnosed Advanced Extranodal Natural KiIler/T-Cell Lymphoma A Randomized Clinical Trial
Xinhua Wang et al.
JAMA ONCOLOGY (2022)
The Clinical Features and Survival Outcome of 107 Newly Diagnosed Advanced Stage Extranodal NK/T-Cell Lymphoma Cases: A Triple-Center Study
Jiwei Li et al.
CANCER MANAGEMENT AND RESEARCH (2021)
Comprehensive analysis of peripheral T-cell and natural killer/T-cell lymphoma in Asian patients: A multinational, multicenter, prospective registry study in Asia
Sang Eun Yoon et al.
LANCET REGIONAL HEALTH-WESTERN PACIFIC (2021)
A five-year retrospective study of treatment outcomes using the L-asparaginase-based regimen as a first-line chemotherapy protocol for patients diagnosed with extranodal NK/T-cell lymphoma, nasal-type, in Thailand
Pongthep Vittayawacharin et al.
HEMATOLOGY (2021)
Extranodal NK-T Cell Lymphoma, Nasal Type: Retrospective Analysis of Real-World Data
Sneha J. Bothra et al.
INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION (2020)
Modified SMILE (mSMILE) and intensity-modulated radiotherapy (IMRT) for extranodal NK-T lymphoma nasal type in a single-center population
Paola Ghione et al.
LEUKEMIA & LYMPHOMA (2020)
Clinical characteristics and survival of extranodal natural killer/T-cell lymphoma: a single-center 12-year retrospective analysis
Yi Chen et al.
LEUKEMIA & LYMPHOMA (2020)
Management of NK/T-Cell Lymphoma, Nasal Type
Pamela B. Allen et al.
JOURNAL OF ONCOLOGY PRACTICE (2019)
Advances in the treatment of extranodal NK/T-cell lymphoma, nasal type
Motoko Yamaguchi et al.
BLOOD (2018)
290PExtranodal NK/T cell lymphoma- nasal type: Experience from an Indian regional cancer centre
S C Saldanha et al.
ANNALS OF ONCOLOGY (2018)
Effectiveness of pegaspargase, gemcitabine, and oxaliplatin (P-GEMOX) chemotherapy combined with radiotherapy in newly diagnosed, stage IE to IIE, nasal-type, extranodal natural killer/T-cell lymphoma
Wen Wei et al.
HEMATOLOGY (2017)
NK/T Cell Lymphoma: A Tertiary Centre Experience
Neeraj Arora et al.
INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION (2017)
NK/T Cell Lymphoma: A Tertiary Centre Experience
Neeraj Arora et al.
INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION (2017)
A phase II prospective study of the Sandwich protocol, L-asparaginase, cisplatin, dexamethasone and etoposide chemotherapy combined with concurrent radiation and cisplatin, in newly diagnosed, I/II stage, nasal type, extranodal natural killer/T-cell lymphoma
Ming Jiang et al.
ONCOTARGET (2017)
Intensity-modulated radiation therapy followed by GDP chemotherapy for newly diagnosed stage I/II extranodal natural killer/T cell lymphoma, nasal type
Yu Huang et al.
ANNALS OF HEMATOLOGY (2017)
Five-year analysis from phase 2 trial of sandwich chemoradiotherapy in newly diagnosed, stage IE to IIE, nasal type, extranodal natural killer/T-cell lymphoma
Li Zhang et al.
CANCER MEDICINE (2016)
The 2016 revision of the World Health Organization classification of lymphoid neoplasms
Steven H. Swerdlow et al.
BLOOD (2016)
DDGP versus SMILE in Newly Diagnosed Advanced Natural Killer/T-Cell Lymphoma: A Randomized Controlled, Multicenter, Open-label Study in China
Xin Li et al.
CLINICAL CANCER RESEARCH (2016)
A prognostic index for natural killer cell lymphoma after non-anthracycline-based treatment: a multicentre, retrospective analysis
Seok Jin Kim et al.
LANCET ONCOLOGY (2016)
Encouraging experience in the treatment of nasal type extra-nodal NK/T-cell lymphoma in a non-Asian population
Shunan Qi et al.
LEUKEMIA & LYMPHOMA (2016)
GDP (Gemcitabine, Dexamethasone, and Cisplatin) Is Highly Effective and Well-Tolerated for Newly Diagnosed Stage IV and Relapsed/Refractory Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type
Jing-jing Wang et al.
MEDICINE (2016)
Phase II trial of concurrent chemoradiotherapy with L-asparaginase and MIDLE chemotherapy for newly diagnosed stage I/II extranodal NK/T-cell lymphoma, nasal type (CISL1008)
Dok Hyun Yoon et al.
ONCOTARGET (2016)
Efficacy of combined gemcitabine, oxaliplatin and pegaspargase (P-gemox regimen) in patients with newly diagnosed advanced-stage or relapsed/refractory extranodal NK/T-cell lymphoma
Jing-hua Wang et al.
ONCOTARGET (2016)
Concurrent Etoposide, Steroid, High-dose Ara-C and Platinum chemotherapy with radiation therapy in localised extranodal natural killer (NK)/T-cell lymphoma, nasal type
Jean-Marie Michot et al.
EUROPEAN JOURNAL OF CANCER (2015)
High-dose methotrexate, etoposide, dexamethasone and pegaspargase (MEDA) combination chemotherapy is effective for advanced and relapsed/refractory extranodal natural killer/T cell lymphoma: a retrospective study
Hao Ding et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2015)
Long-term results of a phase II trial with frontline concurrent chemoradiotherapy followed by consolidation chemotherapy for localized nasal natural killer/T-cell lymphoma
Hui-Jen Tsai et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2015)
A TNM Staging System for Nasal NK/T-Cell Lymphoma
Zheng Yan et al.
PLOS ONE (2015)
Concurrent chemoradiotherapy followed by L-asparaginase-containing chemotherapy, VIDL, for localized nasal extranodal NK/T cell lymphoma: CISL08-01 phase II study
Seok Jin Kim et al.
ANNALS OF HEMATOLOGY (2014)
Recommendations for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The Lugano Classification
Bruce D. Cheson et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Concurrent IMRT and weekly cisplatin followed by GDP chemotherapy in newly diagnosed, stage IE tdso IIE, nasal, extranodal NK/T-Cell lymphoma
Q-H Ke et al.
BLOOD CANCER JOURNAL (2014)
Extranodal natural killer T-cell lymphoma, nasal-type-A new staging system from CSWOG-A multicenter study.
Tongyu Lin et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
First-line combination of gemcitabine, oxaliplatin, and L-asparaginase (GELOX) followed by involved-field radiation therapy for patients with stage IE/IIE extranodal natural killer/T-cell lymphoma
Liang Wang et al.
CANCER (2013)
SMILE for natural killer/T-cell lymphoma: analysis of safety and efficacy from the Asia Lymphoma Study Group
Yok-Lam Kwong et al.
BLOOD (2012)
Phase 2 trial of Sandwich L-asparaginase, vincristine, and prednisone chemotherapy with radiotherapy in newly diagnosed, stage IE to IIE, nasal type, extranodal natural killer/T-cell lymphoma
Ming Jiang et al.
CANCER (2012)
Peripheral T-cell lymphoma: Frequency and distribution in a tertiary referral center in South India
Deepak K. Burad et al.
INDIAN JOURNAL OF PATHOLOGY AND MICROBIOLOGY (2012)
Concurrent Chemoradiotherapy for Localized Nasal Natural Killer/T-Cell Lymphoma: An Updated Analysis of the Japan Clinical Oncology Group Study JCOG0211
Motoko Yamaguchi et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Efficacy of L-asparaginase with methotrexate and dexamethasone (AspaMetDex regimen) in patients with refractory or relapsing extranodal NK/T-cell lymphoma, a phase 2 study
Arnaud Jaccard et al.
BLOOD (2011)
Prospective measurement of Epstein-Barr virus-DNA in plasma and peripheral blood mononuclear cells of extranodal NK/T-cell lymphoma, nasal type
Ritsuro Suzuki et al.
BLOOD (2011)
Phase II Study of SMILE Chemotherapy for Newly Diagnosed Stage IV, Relapsed, or Refractory Extranodal Natural Killer (NK)/T-Cell Lymphoma, Nasal Type: The NK-Cell Tumor Study Group Study
Motoko Yamaguchi et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Clinical differences between nasal and extranasal natural killer/T-cell lymphoma: a study of 136 cases from the International Peripheral T-Cell Lymphoma Project
Wing-yan Au et al.
BLOOD (2009)
Phase I/II Study of Concurrent Chemoradiotherapy for Localized Nasal Natural Killer/T-Cell Lymphoma: Japan Clinical Oncology Group Study JCOG0211
Motoko Yamaguchi et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Phase II Trial of Concurrent Radiation and Weekly Cisplatin Followed by VIPD Chemotherapy in Newly Diagnosed, Stage IE to IIE, Nasal, Extranodal NK/T-Cell Lymphoma: Consortium for Improving Survival of Lymphoma Study
Seok Jin Kim et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
The 2008 WHO classification of lymphomas: implications for clinical practice and translational research
E. S. Jaffe
Hematology-American Society of Hematology Education Program (2009)
Extranodal NK/T-cell lymphoma: diagnosis and treatment cues
Ritsuro Suzuki et al.
HEMATOLOGICAL ONCOLOGY (2008)
International peripheral T-cell and natural killer/T-cell lymphoma study: Pathology findings and clinical outcomes
Julie M. Vose et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Extranodal natural killer T-cell lymphoma, nasal-type: A prognostic model from a retrospective multicenter study
J Lee et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Local tumor invasiveness is more predictive of survival than International Prognostic Index in stage IE/IIE extranodal NK/T-cell lymphoma, nasal type
TM Kim et al.
BLOOD (2005)
Extranodal nasal type NK/T-cell lymphoma: Elucidating clinical prognostic factors for risk-based stratification of therapy
J Lee et al.
EUROPEAN JOURNAL OF CANCER (2005)
Peripheral T-cell lymphoma unspecified (PTCL-U): a new prognostic model from a retrospective multicentric clinical study
A Gallamini et al.
BLOOD (2004)
Use of the World Health Organization (WHO) classification of non-Hodgkin's lymphoma in Mumbai, India: A review of 200 consecutive cases by a panel of five expert hematopathologists
KN Naresh et al.
LEUKEMIA & LYMPHOMA (2004)
Natural killer cell neoplasms: A distinctive group of highly aggressive lymphomas/leukemias
MMC Cheung et al.
SEMINARS IN HEMATOLOGY (2003)
Clinical features of peripheral T-cell lymphomas in 78 patients diagnosed according to the Revised European-American lymphoma (REAL) classification
K Kim et al.
EUROPEAN JOURNAL OF CANCER (2002)
分享论文
